Ikemoto H, Watanabe K, Kosakai N, Hayashi Y, Oguri T, Saito A, Shinohara M, Matsumiya H, Ueda K, Ida S
Jpn J Antibiot. 1985 Nov;38(11):3119-44.
Bacterial isolates from the patients with pulmonary infections have been collected over these 3 years, in collaboration with investigators at 13 hospitals in various parts of Japan for the study on frequency of isolation of pathogens among the patients and their drug susceptibilities. Possible causative pathogens mainly isolated from sputum in patients with lower respiratory tract infections during period from September 1983 to March 1984, were collected. The frequency of bacterial isolates from the sputum and their drug susceptibility on H. influenzae among the various pathogens are discussed. The kinds of bacterial species isolated from the patients with respiratory tract infections associated with chronic bronchitis, chronic capillary bronchitis or bronchiectasis and their relative frequency of isolation were as follows; Total numbers of bacterial isolates collected from various hospitals were 220 strains in 1981, 168 strains 1982 and 258 strains in 1983. H. influenzae was always isolated with highest frequency of 50.5% in 1981, 45.8% in 1982 and 40.7% in 1983, and followed by P. aeruginosa (24.1%), S. aureus (8.2%), S. pneumoniae (7.3%) and K. pneumoniae (5.9%) and E. coli (4.1%) in 1981; P. aeruginosa (30.4%), S. pneumoniae (11.9%), S. aureus (4.8%), K. pneumoniae (3.0%) and E. coli (1.8%) in 1982; P. aeruginosa (26.7%), S. pneumoniae (10.1%), S. aureus (7.8%), K. pneumoniae (3.5%) and E. coli (3.5%) in 1983. The drug susceptibility test of H. influenzae to ampicillin (ABPC), piperacillin (PIPC), mezlocillin (MZPC), sulbenicillin (SBPC), gentamicin (GM), amikacin (AMK), cefotiam (CTM), cefmetazole (CMZ), cefoperazone (CPZ), cefotaxime (CTX), ceftizoxime (CZX), cefmenoxime (CMX) and latamoxef (LMOX) was done by using agar micro-broth dilution methods. H. influenzae was most markedly susceptible to cephems of the third generation, especially to CMX, CZX and CTX by which about 95% of H. influenzae tested were inhibited the growth under the concentration with less than or equal to 0.10 microgram/ml of the drugs. Furthermore, annual changes in susceptibility of H. influenzae to various antibiotics was analyzed over the period from 1981 to 1983. The frequency of S. pneumoniae isolated from patients with chronic bronchitis or bronchiectasis was about 10% in this survey. However, in the case of respiratory infections associated with bacterial pneumonia, the frequencies were as follows; 24.8% (77 cases/311 cases) in 1981, 17.7% (44 cases/248 cases) in 1982, and 11.0% (39 cases/355 cases) in 1983. The frequency of isolation of S. pneumoniae decreased every year.(ABSTRACT TRUNCATED AT 400 WORDS)
在过去3年中,我们与日本各地13家医院的研究人员合作,收集了肺部感染患者的细菌分离株,以研究患者中病原体的分离频率及其药敏情况。收集了1983年9月至1984年3月期间下呼吸道感染患者痰液中主要分离出的可能致病病原体。讨论了各种病原体中痰液细菌分离株的频率及其对流感嗜血杆菌的药敏情况。从患有慢性支气管炎、慢性细支气管炎或支气管扩张症的呼吸道感染患者中分离出的细菌种类及其相对分离频率如下:1981年各医院收集的细菌分离株总数为220株,1982年为168株,1983年为258株。流感嗜血杆菌的分离频率始终最高,1981年为50.5%,1982年为45.8%,1983年为40.7%,其次是铜绿假单胞菌(24.1%)、金黄色葡萄球菌(8.2%)、肺炎链球菌(7.3%)、肺炎克雷伯菌(5.9%)和大肠杆菌(4.1%)(1981年);铜绿假单胞菌(30.4%)、肺炎链球菌(11.9%)、金黄色葡萄球菌(4.8%)、肺炎克雷伯菌(3.0%)和大肠杆菌(1.8%)(1982年);铜绿假单胞菌(26.7%)、肺炎链球菌(10.1%)、金黄色葡萄球菌(7.8%)、肺炎克雷伯菌(3.5%)和大肠杆菌(3.5%)(1983年)。采用琼脂微量肉汤稀释法对流感嗜血杆菌进行了氨苄西林(ABPC)、哌拉西林(PIPC)、美洛西林(MZPC)、磺苄西林(SBPC)、庆大霉素(GM)、阿米卡星(AMK)、头孢替安(CTM)、头孢美唑(CMZ)、头孢哌酮(CPZ)、头孢噻肟(CTX)、头孢唑肟(CZX)、头孢甲肟(CMX)和拉氧头孢(LMOX)的药敏试验。流感嗜血杆菌对第三代头孢菌素最为敏感,尤其是对CMX、CZX和CTX,在药物浓度小于或等于0.10微克/毫升时,约95%的受试流感嗜血杆菌生长受到抑制。此外,分析了1981年至1983年期间流感嗜血杆菌对各种抗生素药敏性的年度变化。在本次调查中,从慢性支气管炎或支气管扩张症患者中分离出肺炎链球菌的频率约为10%。然而,在细菌性肺炎相关的呼吸道感染病例中,频率如下:1981年为24.8%(77例/311例),1982年为17.7%(44例/248例),1983年为11.0%(39例/355例)。肺炎链球菌的分离频率逐年下降。(摘要截选至400字)